Comparative effectiveness of subcutaneous GLP-1 receptor agonists versus SGLT2 inhibitors on metabolic and hepatic outcomes in T2DM with MASLD: a propensity score-matched study.
- DOI
- 10.1007/s40618-026-02976-3
- Published
- 2026 Jul 13
- Container
- Journal of endocrinological investigation
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40618-026-02976-3,
title = {Comparative effectiveness of subcutaneous GLP-1 receptor agonists versus SGLT2 inhibitors on metabolic and hepatic outcomes in T2DM with MASLD: a propensity score-matched study.},
author = {Toffoli B and Sirignano M and Bonato V and Fusaro G and Russo E and Velardi V and Crocè LS and Fabris B and Candido R and Bernardi S},
year = {2026},
journal = {Journal of endocrinological investigation},
doi = {10.1007/s40618-026-02976-3},
url = {https://doi.org/10.1007/s40618-026-02976-3}
}RIS
TY - JOUR TI - Comparative effectiveness of subcutaneous GLP-1 receptor agonists versus SGLT2 inhibitors on metabolic and hepatic outcomes in T2DM with MASLD: a propensity score-matched study. AU - Toffoli B AU - Sirignano M AU - Bonato V AU - Fusaro G AU - Russo E AU - Velardi V AU - Crocè LS AU - Fabris B AU - Candido R AU - Bernardi S PY - 2026 JO - Journal of endocrinological investigation DO - 10.1007/s40618-026-02976-3 UR - https://doi.org/10.1007/s40618-026-02976-3 ER -
APA
B, T., M, S., V, B., G, F., E, R., V, V., LS, C., B, F., R, C., & S, B. (2026). Comparative effectiveness of subcutaneous GLP-1 receptor agonists versus SGLT2 inhibitors on metabolic and hepatic outcomes in T2DM with MASLD: a propensity score-matched study.. Journal of endocrinological investigation. https://doi.org/10.1007/s40618-026-02976-3
Source records
- pubmed · retrieved 2026-09-25T08:18:48.080Z